华海药业：2025年度业绩预减公告

Core Viewpoint - Huahai Pharmaceutical announced a profit warning for the fiscal year 2025, projecting a significant decrease in net profit compared to the previous year, indicating potential challenges ahead for the company [1] Financial Performance - The company expects net profit attributable to shareholders to be between 224 million yuan and 335 million yuan for 2025 [1] - This represents a decrease of approximately 784 million yuan to 894 million yuan compared to the same period last year [1] - The year-on-year decline in net profit is estimated to be around 70% to 80% [1]